Dr Reddy'S Labs Launches Fosaprepitant For Injection In Us Market

Dr Reddy'S Laboratories Ltd Announced Launch Of Fosaprepitant For Injection The Therapeutic Generic Equivalent Of Us Fda Approved Emend (Fosaprepitant) For Injection In The Us Market."We Are Pleased To Be Among The First Generics To Launch This Product," Explained Marc Kikuchi, Chief Executive Officer, North America Generics, Dr.Reddy'S Laboratories."This Is A Great Addition To Our Injectable Portfolio In The Us Market, As We Continue To Augment Our Product Offering And Drive Growth For The Hospital Segment," Added Kikuchi.The Emend For Injection Brand Had Sales Of Approximately Us$ 279 Million Moving Annual Total (Mat) For The Most Recent Twelve Months Ending In July 2019, According To Iqvia Health.Dr. Reddy'S Laboratories Ltd Has A Portfolio Of Products And Services Including Active Pharmaceutical Ingredient (Apls), Custom Pharmaceutical Services, Generics, Biosimilars And Differentiated Formulations. Its Major Therapeutic Areas Of Focus Are Gastrointestinal, Cardiovascular, Diabetology, Oncology, Pain Management And Dermatology.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!